ARPANA EDALA: Open Payments
NPI 1265662969 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 52 payments from 16 companies in 2025. Trend: 2023 $932 · 2024 $730 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $267 |
| Eisai Inc. | 3 | $168 |
| Amgen Inc. | 3 | $167 |
| Lundbeck LLC | 10 | $163 |
| Lilly USA, LLC | 8 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $116 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| ACADIA Pharmaceuticals Inc | 3 | $67 |
| Boston Scientific Corporation | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: REXULTI, Leqembi, TAVNEOS, Kerendia, AUSTEDO XR, MOUNJARO, NUPLAZID, KISUNLA.
Industry payments across AR — which companies pay providers there.
